Could a pill stop Ebola after exposure? More than 250 people in Congo join a trial to find out
More than 250 people in Congo have enrolled in a trial testing whether an experimental antiviral pill can prevent Ebola from developing after exposure. Participants include health workers and patients’ relatives, but the drug’s effectiveness against the outbreak’s Bundibugyo virus has not yet been established.
Source: nwaonline.com
Read the original story →